Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.36% | 50.12% | -10.10% | -39.81% | 27.08% |
| Total Depreciation and Amortization | 5.19% | -12.40% | 5.22% | -1.08% | -59.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.04% | -22.95% | -134.29% | 597.20% | -- |
| Change in Net Operating Assets | 104.97% | -224.88% | 282.38% | 299.38% | 120.77% |
| Cash from Operations | 57.97% | -907.24% | 51.77% | 41.92% | 40.80% |
| Capital Expenditure | -- | -- | -- | 200.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -55.49% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | -- | -100.00% | -67.41% | 473.33% | -- |
| Total Debt Issued | -73.10% | -- | -- | -- | -71.81% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 202.36% | -85.44% | 77.96% | -- |
| Cash from Financing | -74.96% | 4,267.72% | -85.44% | -43.41% | -58.67% |
| Foreign Exchange rate Adjustments | 169.33% | -671.38% | 121.64% | -239.38% | 155.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 380.00% | -433.33% | 100.61% | -197.24% | 4,509.09% |